Feasibility Trial of Intraperitoneal Chemotherapy in Stage IA, IB, IC, II, III, IV and Recurrent Platinum Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma and Stage III and IV Uterine Cancer
Giving chemotherapy directly into the abdomen is called intraperitoneal (IP) chemotherapy.
Because ovarian, fallopian, primary peritoneal and uterine cancer spread in the abdominal
cavity, giving chemotherapy drugs by infusion into the abdominal cavity may result in a
greater dose of the drugs reaching the tumor cells. Intraperitoneal treatments will be
administered through an implantable peritoneal catheter. These catheters are to be inserted
into the peritoneal cavity, tunneled through the subcutaneous tissue, and connected to an
implantable port, which is placed in the subcutaneous tissue of the anterior, inferior
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To determine the proportion of patients who are able to receive 6 cycles of intraperitoneal cisplatin chemotherapy.
Joan Walker, MD
University of Oklahoma
United States: Food and Drug Administration
|University of Oklahoma Health Sciences Center||Oklahoma City, Oklahoma 73104|